PRT062607 (P505-15) HCl

Synonyms: BIIB057, PRT-2607

PRT062607 (P505-15, BIIB057, PRT-2607) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM in cell-free assays, >80-fold selective for Syk than Fgr, PAK5, Lyn, FAK, Pyk2, FLT3, MLK1 and Zap70.

PRT062607 (P505-15) HCl Chemical Structure

PRT062607 (P505-15) HCl Chemical Structure

CAS: 1370261-97-4

Selleck's PRT062607 (P505-15) HCl has been cited by 48 publications

Purity & Quality Control

Batch: Purity: 99.69%
99.69

PRT062607 (P505-15) HCl Related Products

Signaling Pathway

Choose Selective Syk Inhibitors

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Ramos Function assay Inhibition of Syk in anti IgM-stimulated human Ramos cells assessed as BLNK phosphorylation by cellular assay, IC50 = 0.178 μM. 24726806
Ramos B Function assay 30 mins Inhibition of Syk in anti-igM stimulated human Ramos B cells assessed as phospho-BLNK level preincubated for 30 mins followed by anti-IgM stimulation measured after 15 mins by flow cytometric analysis, IC50 = 0.178 μM. 25633741
Ramos B Function assay 30 mins Inhibition of Syk in anti-igM stimulated human Ramos B cells assessed as phospho-BLNK level preincubated for 30 mins followed by anti-IgM stimulation measured after 15 mins by flow cytometric analysis, IC50 = 0.178 μM. 26320624
Ramos Cytotoxicity assay Cytotoxicity against human Ramos cells, IC50 = 0.223 μM. 23151054
Ramos Function assay Inhibition of SYK in human Ramos cells, IC50 = 0.223 μM. 23350847
Jurkat T Function assay 30 mins Inhibition of ZAP70 in anti-CD3 stimulated human Jurkat T cells assessed as SLP76 phosphorylation at Y128 preincubated for 30 mins followed by anti-CD3 stimulation measured after 2 mins by FACS analysis, IC50 = 1.805 μM. 25633741
bone marrow cells Cytotoxicity assay 4 days Cytotoxicity against C57BL/6 mouse bone marrow cells assessed as growth inhibition preincubated for 4 days followed by [3H]-thymidine addition measured after 5 hrs by betaplate counting analysis, IC50 = 5.853 μM. 25633741
bone marrow cells Function assay Inhibition of IL3 dependent proliferation in C57/B16 mouse bone marrow cells using [3H]thymidine by liquid scintillation counting, IC50 = 5.853 μM. 24726806
CHO Function assay Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay, IC50 = 8.6 μM. 25633741
Click to View More Cell Line Experimental Data

Biological Activity

Description PRT062607 (P505-15, BIIB057, PRT-2607) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM in cell-free assays, >80-fold selective for Syk than Fgr, PAK5, Lyn, FAK, Pyk2, FLT3, MLK1 and Zap70.
Targets
Syk [1]
(Cell-free assay)
FGR [1]
(Cell-free assay)
MLK1 [1]
(Cell-free assay)
PYK2 [1]
(Cell-free assay)
YES [1]
(Cell-free assay)
Click to View More Targets
1 nM 81 nM 88 nM 108 nM 123 nM
In vitro
In vitro PRT062607(P505-15) anti-SYK activity is at least 80-fold greater than its affinity for other kinases. at least 80-fold greater than its affinity for other kinases. PRT062607 potently inhibits B cell antigen receptor-mediated B cell signaling and activation (IC50 0.27 and 0.28 μM, respectively) and Fcε receptor 1-mediated basophil degranulation (IC50 0.15 μM). [1] PRT062607 inhibits BCR-dependent secretion of the chemokines CCL3 and CCL4 by CLL cells, and leukemia cell migration toward the tissue homing chemokines CXCL12, CXCL13, and beneath stromal cells. PRT062607 furthermore inhibits Syk and extracellular signal-regulated kinase phosphorylation after BCR triggering. [2]
Kinase Assay fluorescence resonance energy transfer (FRET) assay
The extent of substrate phosphorylation by Syk is measured in the presence of various PRT062607 concentrations. Syk activity is determined by a fluorescent antibody specific for phosphorylated tyrosine by using the increase of FRET. Twelve concentrations are tested for dose response. Specificity and potency of kinase inhibition is determined by evaluation of PRT062607 in the Millipore KinaseProfiler panel of 270 independent purified kinase assays. For profiling, PRT062607 is tested in duplicate at two concentrations at a fixed concentration of ATP. Subsequently, IC50 determinations using the radioactive assays are carried out at an ATP concentration optimized for each individual kinase. All radioactive ATP incorporationenzyme assays are performed at Millipore.
Cell Research Cell lines Syk-dependent BaF3 cell
Concentrations ~6 μM
Incubation Time 3 days
Method

CellTiter Glo

Experimental Result Images Methods Biomarkers Images PMID
Western blot p-Syk / Syk / p-FLT3 / FLT3 / p-STAT5 / STAT5 Bcl6 24525236
Growth inhibition assay Cell viability 28064214
In Vivo
In vivo The pharmacokinetic/pharmacodynamic relationship predicted that 70% Syk suppression is maintained in mice over a 24h period after 30 mg/kg dosing. At 15 mg/kg, Syk inhibition ranges from 7.5% (Cmin) to 78.4% (Cmax) with an average inhibition of 67% over 24 h. Oral administration of PRT062607 produced dose-dependent anti-inflammatory activity in two rodent models of rheumatoid arthritis. Statistically significant efficacy is observed at concentrations that specifically suppressed Syk activity by 67%.[1]
Animal Research Animal Models Mouse Collagen Antibody-Induced Arthritis Model
Dosages 5, 15, 30 mg/kg, b.i.d.
Administration Oral
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01652937 Withdrawn
Rheumatoid Arthritis
Biogen
August 2012 Phase 2

Chemical Information & Solubility

Molecular Weight 429.91 Formula

C19H23N9O.HCl

CAS No. 1370261-97-4 SDF Download PRT062607 (P505-15) HCl SDF
Smiles C1CCC(C(C1)N)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)N4N=CC=N4)C(=O)N.Cl
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 86 mg/mL ( (200.04 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 86 mg/mL

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy PRT062607 (P505-15) HCl | PRT062607 (P505-15) HCl supplier | purchase PRT062607 (P505-15) HCl | PRT062607 (P505-15) HCl cost | PRT062607 (P505-15) HCl manufacturer | order PRT062607 (P505-15) HCl | PRT062607 (P505-15) HCl distributor